Graduate School of Life Science and Systems Engineering, Kyushu Institute of Technology,; Present address: Department of Dermatology, Kurume University School of Medicine, Fukuoka.
Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Allergol Int. 2010 Sep;59(3):267-275. doi: 10.2332/allergolint.09-OA-0153. Epub 2010 May 25.
Airway remodeling is a repair process occurring after airway injury; its primary histopathological features are subepithelial fibrosis and smooth muscle thickening of the bronchi. These histopathological changes are considered to occur due to bronchial smooth muscle cells (bSMC) that secrete extracellular matrix (ECM) proteins, which work as chemoattractants and influence cell migration. Therefore, we examined the interaction between bSMCs and ECM proteins in vitro for understanding the remodeling process in the bronchi.
bSMCs were cultured to collect a bSMC-conditioned medium. Using the bSMC-conditioned medium thus obtained, we performed a cell migration assay, characterized beta integrin expression, and identified ECM proteins and matrix metalloproteinases by western blotting and gelatin zymography, respectively.
The response of bSMC migration to bSMC-conditioned medium increased with time in culture, and fibronectin (FIB) was detected as a chemoattractant for bSMCs in bSMC-conditioned medium by western blot analysis and a cell migration assay using anti-FIB antibodies. The involvement of beta1 integrin in the migration of bSMCs toward FIB contained in bSMC-conditioned medium was demonstrated by inhibition of cell migration using anti-beta1 integrin antibodies. Expression of beta1 integrin on bSMCs was confirmed by using a beta-integrin-mediated cell adhesion array. In addition, metalloproteinases detected in bSMC-conditioned medium by gelatin zymography were suggested to be matrix metalloproteinase-1 and 2 by western blotting and amino acid sequencing.
Our results suggest that FIB and matrix metalloproteinases secreted from bSMCs might play major roles in bSMC migration in the process of airway remodeling.
气道重塑是气道损伤后的修复过程;其主要组织病理学特征是支气管黏膜下纤维化和平滑肌增厚。这些组织病理学变化被认为是由于支气管平滑肌细胞(bSMC)分泌细胞外基质(ECM)蛋白引起的,这些蛋白作为趋化因子起作用,并影响细胞迁移。因此,我们在体外研究了 bSMC 和 ECM 蛋白之间的相互作用,以了解支气管的重塑过程。
培养 bSMC 以收集 bSMC 条件培养基。使用由此获得的 bSMC 条件培养基,我们进行了细胞迁移测定,表征了β整合素的表达,并通过 Western blot 和明胶酶谱法分别鉴定 ECM 蛋白和基质金属蛋白酶。
bSMC 迁移对 bSMC 条件培养基的反应随培养时间的增加而增加,通过 Western blot 分析和使用抗 FIB 抗体的细胞迁移测定,在 bSMC 条件培养基中检测到纤连蛋白(FIB)作为 bSMC 的趋化因子。通过使用抗β1 整合素抗体抑制细胞迁移,证明了β1 整合素在 bSMC 向 bSMC 条件培养基中包含的 FIB 迁移中的参与。通过使用β整合素介导的细胞黏附阵列,证实了 bSMC 上β1 整合素的表达。此外,通过明胶酶谱法在 bSMC 条件培养基中检测到的金属蛋白酶通过 Western blot 和氨基酸测序被认为是基质金属蛋白酶-1 和 2。
我们的结果表明,bSMC 分泌的 FIB 和基质金属蛋白酶可能在气道重塑过程中 bSMC 迁移中起主要作用。